Anti-hypertensive effect of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA sONE in a rat model of salt-sensitive hypertension

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6981-7. eCollection 2015.

Abstract

The present study aims to test whether Lycium barbarum L. has anti-hypertensive effect through regulating expression of lncRNA sONE in a rat model of salt-sensitive hypertension. Nine weeks old borderline hypertensive rats (BHRs) were divided into 4 groups receiving high (8% NaCl), medium (0.25% NaCl, as control group), and low salt diet (0.015% NaCl) for 16 weeks, respectively, while the fourth group (high salt + L. barbarum group) fed with high salt diet for 12 weeks, then followed by 8% NaCl and L. barbarum treatment for 4 weeks. Body weight and blood pressure were recorded biweekly. Salt-sensitive hypertension was successfully induced by 12-week high salt diet in BHR model. Blood pressure was significantly increased in the model (P < 0.05), and L. barbarum treatment reversed the elevated blood pressure to normal level. Expression of lncRNA sONE was significantly reduced and eNOS expression level was dramatically improved in the hypertension model rats with the L. barbarum compared with that receiving high salt diet. Our results indicated that L. barbarum L. had anti-hypertensive effect and might lower blood pressure by suppressing the expression of lncRNA sONE in BHR model.

Keywords: Lycium barbarum L.; endothelial nitric oxide synthase; lncRNA sONE; salt-sensitive hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antihypertensive Agents / isolation & purification
  • Antihypertensive Agents / pharmacology*
  • Blood Pressure / drug effects*
  • Cells, Cultured
  • Crosses, Genetic
  • Disease Models, Animal
  • Down-Regulation
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Female
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Hypertension / drug therapy*
  • Hypertension / genetics
  • Hypertension / metabolism
  • Hypertension / physiopathology
  • Kidney / blood supply*
  • Lycium* / chemistry
  • Male
  • Nitric Oxide Synthase Type III / metabolism
  • Phytotherapy
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Plants, Medicinal
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*
  • Rats, Inbred SHR
  • Rats, Wistar
  • Sodium Chloride, Dietary*
  • Time Factors

Substances

  • Antihypertensive Agents
  • Plant Extracts
  • RNA, Long Noncoding
  • Sodium Chloride, Dietary
  • long noncoding RNA sONE, rat
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat